- Patent Title: Methods of treating intraocular pressure with activators of Tie-2
-
Application No.: US17150430Application Date: 2021-01-15
-
Publication No.: US11666558B2Publication Date: 2023-06-06
- Inventor: Kevin Peters
- Applicant: EyePoint Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: EyePoint Pharmaceuticals, Inc.
- Current Assignee: EyePoint Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: A61K31/426
- IPC: A61K31/426 ; A61P27/06 ; A61P27/02 ; A61K31/427 ; A61K31/428 ; A61K31/497 ; A61K31/496 ; A61K31/513 ; A61K31/433
Abstract:
Disclosed herein are compounds effective for activation of Tie-2 and inhibition of HPTP-beta. The compounds can provide effective therapy for eye conditions associated with angiogenesis, for example, intraocular pressure, ocular hypertension, and glaucoma.
Public/Granted literature
- US20210386713A1 METHODS OF TREATING INTRAOCULAR PRESSURE WITH ACTIVATORS OF TIE-2 Public/Granted day:2021-12-16
Information query
IPC分类:
